Papers
8
Total Citations
111
H-Index
6
About
Mirjam Crul is a leading researcher in oncology pharmacy, specializing in the safe and efficient preparation of hazardous drugs. Her work focuses on robotic compounding systems, aseptic techniques, and the handling of monoclonal antibodies. Crul’s major contributions include pioneering comparative studies that demonstrate how robotic systems like APOTECAchemo significantly reduce environmental and external cross-contamination of cytotoxic drugs compared to manual methods, as shown in her highly cited 2019 paper (25 citations). She has also advanced understanding of dosing accuracy, precision, and production efficiency, with her 2020 study on robotic versus manual compounding (17 citations) and 2023 analysis of production time and capacity (7 citations) informing best practices in hospital pharmacies. Her research extends to the stability of monoclonal antibodies, revealing how compounding methods affect aggregate formation and antibody integrity (5 citations). With over 110 citations across her key works, Crul’s findings have global impact, influencing safety protocols and economic decisions, such as vial sharing strategies (13 citations). As an active member of the European Society of Oncology Pharmacy, she shapes the future of the profession through surveys on post-production handling and member perspectives, making her a pivotal voice in advancing oncology pharmacy practice.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8